Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
FOS Advisors is a boutique healthcare advisory firm focused on mergers and acquisitions, strategic partnerships, and growth consulting for MedTech and Digital Health companies. The firm is not a drug developer; instead, it advises emerging and established healthcare technology companies on M&A readiness, market entry, commercialization strategy, investor diligence, and strategic transactions. Its sector emphasis appears centered on medical devices, minimally invasive surgery, diagnostics, and digital health rather than therapeutics. FOS Advisors also works closely with affiliated investment entities such as FOS Capital Partners, which can provide capital access and principal investment support to selected opportunities. Overall, FOS Advisors operates as a specialized transaction and strategic advisory platform serving the healthcare technology ecosystem.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on FOS Advisors.